TATE-RGD dual-targeting tracer
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TATE-RGD dual-targeting tracer, covering 2025-07-09 to 2025-07-09. Get the full timeline:
Most recent: Clinical Trial Update: A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors [EARLY_Phase 1]